key: cord-0828691-ncfnh3dl
authors: Canarutto, Daniele; Del Barba, Paolo; Di Frenna, Marianna; Del Tedesco, Federica; Pajno, Roberta; Guarneri, Maria Pia; Barera, Graziano
title: Prolonged asymptomatic SARS‐CoV‐2 infection in a child receiving immunosuppressive therapy
date: 2020-07-31
journal: Pediatr Pulmonol
DOI: 10.1002/ppul.24983
sha: 503dd66757e3ba658b71ccd3bff52bd25240cd62
doc_id: 828691
cord_uid: ncfnh3dl

nan

To the Editor,

The current coronavirus disease 2019 (COVID-19) pandemic burden is the product of the high infectivity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), variable clinical presentation, and high lethality of the disease. Children are relatively spared by the disease, but there is increasing concern regarding their role in the chain of contagion, 1 and little data is available concerning the course of COVID-19 in children receiving immunosuppressive agents.

We report a case of familial transmission of SARS-CoV-2 whereby a girl became infected while receiving immunosuppressive therapy; while she did not display any symptom or sign of disease, more than 30 days passed before she eventually tested negative.

Her father, a 46-year-old hospital employee, not involved in patient care, developed fever, cough, and rhinitis on 22nd March. As illustrated in Figure 1 

Brief report: International perspectives on the pediatric COVID-19 experience

COVID-19 cardiac involvement in a 38-day old infant

Favourable outcome of coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression

The isolation period should be longer: Lesson from a child infected with SARS-CoV-2 in Chongqing

home-care-for-patients-with-suspected-novelcoronavirus-(ncov)-infection-presenting-with-mild-symptoms-andmanagement-of-contacts